Promis-hfpef研究
WebOct 9, 2024 · In 228 patients with HFpEF from the multicenter PROMIS-HFpEF study (Prevalence of Microvascular Dysfunction in Heart Failure With Preserved Ejection … WebJan 21, 2024 · Using the prospective multinational PROMIS-HFpEF study (Prevalence of Microvascular Dysfunction in HFpEF; n = 182; 54.6% women), we compared clinical and biomarker correlates of CMD (defined as coronary flow reserve [CFR] <2.5) between men and women with HFpEF. We used lasso penalized regression to analyse 242 biomarkers …
Promis-hfpef研究
Did you know?
WebJun 23, 2024 · HFpEFの病態は複雑で、加齢、肥満、高血圧、糖尿病、心房細動、肺高血圧、冠動脈疾患など、様々な併存疾患が関与しているとされる。. このこと ... Web文献「駆出率が保たれた心不全における冠微小循環障害と心不全入院および死亡率との関連性:promis-hfpef研究におけるフォローアップ」の詳細情報です。j-global 科学技術総合リンクセンターは研究者、文献、特許などの情報をつなぐことで、異分野の知や意外な発見などを支援する新しい ...
WebWe analyzed blood samples and data from the PROMIS-HFpEF study (Prevalence of Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction), the design of which has been described previously.10 In brief, PROMIS-HFpEF was a multicenter, observational study to evaluate the prevalence and correlates of coronary microvascular … WebIn the PROMIS-HFpEF study, echocardiographic measurement of CFR in the left anterior descending coronary artery identified CMD in 75% of the participants, using a CFR …
WebPrevalenceand correlates of coronary microvasculardysfunction in heart failurewith preserved ejection fraction: PROMIS-HFpEF Sanjiv J. Shah1†, Carolyn S.P. Lam2,3†, Sara Svedlund4, Antti Saraste5, Camilla Hage6, Ru-San Tan2, Lauren Beussink-Nelson1, Maria Lagerstro¨m Fermer7, Malin A. Broberg7, Li-Ming Gan7,8,9*, and Lars H. Lund6* 1Division … WebJan 7, 2024 · The recent PROMIS-HFpEF trial was the first prospective, multinational, multicentre, observational study, which enrolled patients with HFpEF without obstructive CAD. ... Beyond the HFpEF paradigm, there is evidence that co-morbidities-associated chronic low-grade inflammation also can trigger endothelial-independent coronary …
WebJan 21, 2024 · Using the prospective multinational PROMIS-HFpEF study (Prevalence of Microvascular Dysfunction in HFpEF; n = 182; 54.6% women), we compared clinical and …
WebAug 27, 2024 · This editorial refers to ‘Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF’ †, by S.J. Shah et al., on page 3439. There is increasing documentation that coronary microvascular dysfunction (CMD)-related subendocardial ischaemia contributes to left ventricular … ibr mechatronikWeb来自专栏： uPAR文献精读 共6篇a 。 。 ... monday auburnWebSep 20, 2024 · 本项研究推导并验证了一个简单的attr-cm评分，来预测hfpef患者为attr-cm的风险。 作者：王崇慧. 来源：北一心语. 研究方法. 本研究对2013年5月10日至2024年8月31日在明尼苏达州罗切斯特市梅奥诊所的666名hf（ef≥40%）和疑似attr-cm患者进行回顾性队列研 … monday at racineWebAug 27, 2024 · Discussion. In patients with heart failure and a preserved ejection fraction, SGLT2 inhibition with empagliflozin led to a 21% lower relative risk in the composite of cardiovascular death or ... ibroadcast downloadmonday attireWebNov 1, 2024 · Methods and Results. We assessed the 1-year outcomes in patients from the PROMIS-HFpEF study, a prospective observational study of patients with chronic stable HFpEF undergoing coronary flow reserve measurements. Outcomes were (1) time to cardiovascular (CV) death/first HF hospitalization, (2) CV death/recurrent HF … ibrn portlandWeb事实上，美国国家心脏、肺和血液研究所赞助的wise（女性缺血综合征评估）研究的数据表明，inoca患者的预后更差，低cfr是mace的可靠独立预测因子[5]。 这些发现随后被扩展，发现CFR降低（CFR＜2）是女性和男性MACE的有力增量预测因子[2]。 ibroadcast flac